Chemed (NYSE:CHE – Free Report) had its target price increased by Royal Bank of Canada from $633.00 to $667.00 in a research report released on Friday,Benzinga reports. The firm currently has an outperform rating on the stock.
Separately, StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.
View Our Latest Research Report on Chemed
Chemed Price Performance
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is presently 10.05%.
Insider Buying and Selling at Chemed
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Brian C. Judkins purchased 145 shares of the firm’s stock in a transaction on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the company. CIBC Asset Management Inc increased its holdings in shares of Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock valued at $242,000 after purchasing an additional 22 shares during the period. CBIZ Investment Advisory Services LLC increased its holdings in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock valued at $30,000 after purchasing an additional 22 shares during the period. CIBC Private Wealth Group LLC increased its holdings in shares of Chemed by 13.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock valued at $98,000 after purchasing an additional 22 shares during the period. EP Wealth Advisors LLC increased its holdings in shares of Chemed by 1.9% in the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock valued at $814,000 after purchasing an additional 25 shares during the period. Finally, Independent Advisor Alliance increased its holdings in shares of Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after purchasing an additional 25 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Further Reading
- Five stocks we like better than Chemed
- What does consumer price index measure?
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- The How and Why of Investing in Gold Stocks
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.